Research progress on latent tuberculosis infection in medical staff

doi:10.19982/j.issn.1000-6621.20240291

Abstract

Abstract:

Tuberculosis (TB) is an important public health problem in China. Early management of latent tuberculosis infection (LTBI) is one of the important contents of TB control strategy. Affected by the specific working environment, medical staff is one of the high-risk groups of LTBI, and the risk of progressing to active TB is also extremely high, which has a serious impact at the society, public health and the individuals. Therefore, it is urgent to improve attention to the LTBI management of medical staff. This article reviewed the current situation, screening strategy, influencing factors and management plans of LTBI in medical staff, in order to improve the awareness of LTBI-related issues among medical staff, clarify relevant personal and occupational risk factors, and provide reference for strengthening TB prevention and control in medical institutions and reducing occupational hazards.

Key words: Mycobacterium tuberculosis, Medical staff, hospital, Mycobacterium infections, Occupational exposure, Review literature as topic

CLC Number:

Chen Yujie, Wang Linghua, Cheng Xiaoyan, Li Huiyuan. Research progress on latent tuberculosis infection in medical staff[J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1541-1547. doi: 10.19982/j.issn.1000-6621.20240291

References 64

[1]	World Health Organization. Global tuberculosis report 2023. Geneva: World Health Organization, 2023.
[2]	Houben RM, Dodd PJ. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med, 2016, 13(10):e1002152. doi:10.1371/journal.pmed.1002152.
[3]	张思文. 某医疗机构结核潜伏性感染情况及相关因素分析. 长春:吉林大学, 2021.
[4]	Hu X, Chen C, Gao Q, et al. Latent tuberculosis infection and infection-associated risk factors for miner workers with silicosis in eastern China. BMC Pulm Med, 2024, 24(1):177. doi:10.1186/s12890-024-02985-z. pmid: 38622607
[5]	肖海浩, 张言斌. 结核分枝杆菌潜伏感染研究进展. 实用医学杂志, 2022, 38(6): 664-668. doi:10.3969/j.issn.1006-5725.2022.06.003.
[6]	Liu Y, Zhang L, Chen Y, et al. Incidence and Risk Factors of Active Tuberculosis Among Hospitalized Patients with Latent Tuberculosis Infection in China: A Cohort Study. Infect Drug Resist, 2024, 17:953-960. doi:10.2147/IDR.S447245. pmid: 38495623
[7]	Guo HY, Zhong QH, Zhou J, et al. Risk of prevalence of latent tuberculosis infection in health care workers-an idiographic meta-analysis from a Chinese perspective. J Thorac Dis, 2021, 13(4):2378-2392. doi:10.21037/jtd-20-1612.
[8]	高磊, 张慧, 胡茂桂, 等. 基于多中心调查数据和空间统计模型的全国结核分枝杆菌潜伏感染率估算. 中国防痨杂志, 2022, 44(1): 54-59. doi:10.19982/j.issn.1000-6621.20210661.
[9]	Apriani L, McAllister S, Sharples K, et al. Latent tuberculosis infection in healthcare workers in low- and middle-income countries: an updated systematic review. Eur Respir J, 2019, 53(4):1801789. doi:10.1183/13993003.01789-2018.
[10]	Coppeta L, Pietroiusti A, Neri A, et al. Prevalence and Risk Factors for Latent Tuberculosis Infection among Healthcare Workers in a Low Incidence Country. Open Respir Med J, 2019, 13:1-4. doi:10.2174/1874306401913010001. pmid: 31908683
[11]	Almohaya A, Aldrees A, Akkielah L, et al. Latent tuberculosis infection among health-care workers using Quantiferon-TB Gold-Plus in a country with a low burden for tuberculosis: prevalence and risk factors. Ann Saudi Med, 2020, 40(3): 191-199. doi:10.5144/0256-4947.2020.191. pmid: 32493098
[12]	Park JS. The Prevalence and Risk Factors of Latent Tuberculosis Infection among Health Care Workers Working in a Tertiary Hospital in South Korea. Tuberc Respir Dis (Seoul), 2018, 81(4): 274-280. doi:10.4046/trd.2018.0020.
[13]	Dorman SE, Belknap R, Graviss EA, et al. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med, 2014, 189(1): 77-87. doi:10.1164/rccm.201302-0365OC.
[14]	Aldhawyan NM, Alkhalifah AK, Kofi M, et al. Prevalence of Latent Tuberculosis Infection Among Nurses Working in Critical Areas at a Tertiary Care Hospital in Riyadh, Saudi Arabia. Cureus, 2024, 16(2): e53389. doi:10.7759/cureus.53389.
[15]	孙娟, 卞雅彬, 马丽萍, 等. 结核病医院护士结核潜伏感染和发病风险的评估. 中国医刊, 2019, 54(6): 670-673. doi:10.3969/j.issn.1008-1070.2019.06.026.
[16]	赵冰. 医务人员结核分枝杆菌感染状况动态分析及新型ELISA诊断肺结核效能的研究. 北京: 中国疾病预防控制中心, 2019.
[17]	Zhou F, Zhang L, Gao L, et al. Latent tuberculosis infection and occupational protection among health care workers in two types of public hospitals in China. PLoS One, 2014, 9(8): e104673. doi:10.1371/journal.pone.0104673.
[18]	周林, 初乃惠, 陆伟. 高危人群结核分枝杆菌潜伏感染检测及预防性治疗专家共识. 中国防痨杂志, 2021, 43(9): 874-878. doi:10.3969/j.issn.1000-6621.2021.09.004.
[19]	World Health Organization. Use of alternative interferon-gamma release assays for the diagnosis of TB infection-WHO Policy Statement. Geneva: World Health Organization, 2022.
[20]	Anwar MM, Ahmed DM, Elareed HR, et al. Screening for Latent Tuberculosis among Healthcare Workers in an Egyptian Hospital Using Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test. Indian J Occup Environ Med, 2019, 23(3): 106-111. doi:10.4103/ijoem.IJOEM_184_19. pmid: 31920258
[21]	饶立歆, 蒋鸿琳, 陈静, 等. 我国结核病防治相关医务工作者结核分枝杆菌潜伏感染现况的Meta分析. 首都公共卫生, 2022, 16(1): 17-22. doi:10.16760/j.cnki.sdggws.2022.01.009.
[22]	卢鹏, 王荣, 刘家松, 等. 结核菌素皮肤试验诊断结核分枝杆菌潜伏感染学校人群预防性服药临界值的确定. 中国防痨杂志, 2022, 44(8): 797-801. doi:10.19982/j.issn.1000-6621.20220197.
[23]	卢鹏, 刘巧, 竺丽梅, 等. 中国东部地区结核菌素试验诊断结核病感染临界值的确定:基于人群的现况调查. 中华流行病学杂志, 2020, 41(3): 363-367. doi:10.3760/cma.j.issn.0254-6450.2020.03.016.
[24]	赵敏, 董清, 江秀菁, 等. 结核定点医院医护人员结核潜伏感染对比研究. 中华医院感染学杂志, 2019, 29(16): 2537-2541. doi:10.11816/cn.ni.2019-182094.
[25]	Theel ES, Hilgart H, Breen-Lyles M, et al. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers. J Clin Microbiol, 2018, 56(7): e00614-18. doi:10.1128/JCM.00614-18.
[26]	Cui X, Gao L, Cao B. Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries. Int J Infect Dis, 2020, 92S:S37-S40. doi:10.1016/j.ijid.2020.02.034.
[27]	Li H, Xin H, Qian S, et al. Testing of tuberculosis infection among Chinese adolescents born after terminating the Bacillus Calmette-Guérin booster vaccination: subgroup analysis of a population-based cross-sectional study. Front Med, 2017, 11(4):528-535. doi:10.1007/s11684-017-0573-0.
[28]	Ruhmald M, Aggerbeck H, Gallardo RV, et al. Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial. Lancet Respir Med, 2017, 5(4): 259-268. doi:10.1016/S2213-2600(16)30436-2.
[29]	Nikitina IY, Karpina NL, Kasimcevao V, et al. Comparative performance of QuantiFERON-TB Gold versus skin test with tuberculosis recombinant allergen (Diaskintest) among patients with suspected pulmonary tuberculosis in Russia. Int J Infect Dis, 2019, 86: 18-24. doi:10.1016/j.ijid.2019.06.014. pmid: 31269455
[30]	Prado TN do, Riley LW, Sanchez M, et al. Prevalence and risk factors for latent tuberculosis infection among primary health care workers in Brazil. Cad Saude Publica, 2017, 33(12): e00154916. doi:10.1590/0102-311X00154916.
[31]	Meregildo-Rodriguez ED, Yuptón-Chávez V, Asmat-Rubio MG, et al. Latent tuberculosis infection (LTBI) in health-care workers: a cross-sectional study at a northern Peruvian hospital. Front Med (Lausanne), 2023, 10: 1295299. doi:10.3389/fmed.2023.1295299.
[32]	陈瑞麒, 张明五, 王伟, 等. 浙江省常山县农村老年人结核分枝杆菌潜伏感染情况及影响因素. 中国防痨杂志, 2024, 46(4): 383-389. doi:10.19982/j.issn.1000-6621.20230399.
[33]	Sadaf R, Munir T, Farrukh S, et al. Prevalence of latent tuberculosis infection in healthcare workers in tertiary care hospitals of Pakistan. Pak J Med Sci, 2020, 36(2): 198-202. doi:10.12669/pjms.36.2.936. pmid: 32063959
[34]	李艳丽, 李燕, 佘凯丽, 等. 山东省部分结核病定点医院护理人员潜伏感染现状及风险因素分析. 山东大学学报(医学版), 2022, 60(4): 107-112. doi:10.6040/j.issn.1671-7554.0.2021.1352.
[35]	Kumar MG, Joseph B, Goud BR, et al. Risk of Tuberculosis Infection among Healthcare Workers in a Tertiary Care Hospital in Bengaluru City. Indian J Occup Environ Med, 2019, 23(2): 83-89. doi:10.4103/ijoem.IJOEM_269_18. pmid: 31619881
[36]	He GX, Wang LX, Chai SJ, et al. Risk factors associated with tuberculosis infection among health care workers in Inner Mongolia, China. Int J Tuberc Lung Dis, 2012, 16(11): 1485-1491. doi:10.5588/ijtld.12.0193. pmid: 22964074
[37]	Chen B, Gu H, Wang X, et al. Prevalence and determinants of latent tuberculosis infection among frontline tuberculosis healthcare workers in southeastern China: A multilevel analysis by individuals and health facilities. Int J Infect Dis, 2019, 79: 26-33. doi:10.1016/j.ijid.2018.11.010. pmid: 30471404
[38]	Islam MS, Gurley ES, Banu S, et al. Prevalence and incidence of tuberculosis infection among healthcare workers in chest diseases hospitals, Bangladesh: Putting infection control into context. PLoS One, 2023, 18(9): e0291484. doi:10.1371/journal.pone.0291484.
[39]	Sahiledengle B, Tekalegn Y, Woldeyohannes D. The critical role of infection prevention overlooked in Ethiopia, only one-half of health-care workers had safe practice: A systematic review and meta-analysis. PLoS One, 2021, 16(1): e0245469. doi:10.1371/journal.pone.0245469.
[40]	Shi CL, Xu JC, Chen H, et al. Risk factors of latent tuberculosis infection and immune function in health care workers in Suzhou, China. J Thorac Dis, 2018, 10(12): 6742-6752. doi:10.21037/jtd.2018.10.112.
[41]	Erawati M, Andriany M. Determinants of latent tuberculosis infection among nurses at public health centers in Indonesia. Belitung Nurs J, 2022, 8(1): 28-34. doi:10.33546/bnj.1846.
[42]	Ngo CQ, Manabe T, Vu GV, et al. Difficulties in tuberculosis infection control in a general hospital of Vietnam: a knowledge, attitude, and practice survey and screening for latent tuberculosis infection among health professionals. BMC Infect Dis, 2019, 19(1): 951. doi:10.1186/s12879-019-4593-z.
[43]	Main S, Dwihardiani B, Hidayat A, et al. Knowledge and attitudes towards TB among healthcare workers in Yogyakarta, Indonesia. Public Health Action, 2022, 12(3): 133-140. doi:10.5588/pha.22.0017. pmid: 36160721
[44]	Deng Y, Liu Y, Li Y, et al. Isolation measures and protection awareness are significant for latent tuberculosis infection: a cross-sectional study based on T-SPOT.TB among health care workers in China. Epidemiol Infect, 2019, 147: e120. doi:10.1017/S0950268818002777.
[45]	何琳, 戚巍, 唐诗邈, 等. 医疗机构卫生人员结核分枝杆菌感染的危险因素研究. 中华劳动卫生职业病杂志, 2024, 42(2): 96-101. doi:10.3760/cma.j.cn121094-20230803-00273.
[46]	Marme G, Rutherford S, Harris N. What tuberculosis infection control measures are effective in resource-constrained primary healthcare facilities? A systematic review of the literature. Rural Remote Health, 2023, 23(1): 7175. doi:10.22605/RRH7175.
[47]	Cho SY, Nham E, Chung DR, et al. Effect of a Latent Tuberculosis Infection Programme for Healthcare Workers in a Country with an Intermediate Tuberculosis Burden. J Hosp Infect, 2023: S0195- 6701(23)00382-1. doi:10.1016/j.jhin.2023.11.009.
[48]	中华人民共和国国家卫生健康委员会办公厅. 中国结核病预防控制工作技术规范(2020年版). 国卫办疾控函〔2020〕279号. 2020-04-02.
[49]	World Health Organization. Technical Consultation on latent TB infection management: research in support of scale-up. Geneva: World Health Organization, 2019.
[50]	Chen B, Liu M, Gu H, et al. Implementation of tuberculosis infection control measures in designated hospitals in Zhejiang Province, China: are we doing enough to prevent nosocomial tuberculosis infections?. BMJ Open, 2016, 6(3):e010242. doi:10.1136/bmjopen-2015-010242.
[51]	杨正贵, 蒋泽顺, 韩雪, 等. 注射用母牛分枝杆菌对HIV合并结核潜伏感染者干预效果观察研究. 宁夏医学杂志, 2023, 45(10): 928-930. doi:10.13621/j.1001-5949.2023.10.0928.
[52]	张梦娴, 王倪, 黄飞, 等. 中国结核病疫苗研发现状及展望. 中国防痨杂志, 2023, 45(2): 125-129. doi:10.19982/j.issn.1000-6621.20220267.
[53]	应池清, 何畅, 徐凯进, 等. 结核潜伏感染诊治进展. 浙江大学学报(医学版), 2022, 51(6):691-696. doi:10.3724/zdxbyxb-2022-0445.
[54]	马艳, 成诗明. 加速我国结核潜伏感染筛查与预防性治疗的建议. 实用医学杂志, 2023, 39(11): 1335-1340. doi:10.3969/j.issn.1006-5725.2023.11.003.
[55]	Wang F, Ren Y, Liu K, et al. Large gap between attitude and action in tuberculosis preventive treatment among tuberculosis-related healthcare workers in eastern China. Front Cell Infect Microbiol, 2022, 12: 991400. doi:10.3389/fcimb.2022.991400.
[56]	World Health Organization. WHO Policy on TB Infection Control in Health-Care Facilities,Congregate Settings and Households. Geneva: World Health Organization, 2009.
[57]	World Health Organization. WHO issues updated recommendations on TB Infection Prevention and Control. Geneva: World Health Organization, 2019.
[58]	商亚丽, 范月玲, 王春蒲, 等. 山西省结核病定点医疗机构结核感染控制现状调查. 中国公共卫生管理, 2022, 38(6): 774-776. doi:10.19568/j.cnki.23-1318.2022.06.0016.
[59]	王晓宁. 我国部分地区结核防治机构结核感染控制现况及县级机构模式的建立. 北京: 中国疾病预防控制中心, 2019.
[60]	Sharma D, Sharma J, Deo N, et al. Prevalence and risk factors of tuberculosis in developing countries through health care workers. Microb Pathog, 2018, 124: 279-283. doi:10.1016/j.micpath.2018.08.057.
[61]	Wang XN, He TL, Geng MJ, et al. Prevalence of and risk factors for tuberculosis among healthcare workers in Chinese tuberculosis facilities. Infect Dis Poverty, 2018, 7(1): 26. doi:10.1186/s40249-018-0407-6.
[62]	Szturmowicz M, Broniarek-Samson B, Demkow U. Prevalence and risk factors for latent tuberculosis in polish healthcare workers: the comparison of tuberculin skin test and interferon-gamma release assay (IGRA) performance. J Occup Med Toxicol, 2021, 16(1): 38. doi:10.1186/s12995-021-00326-y.
[63]	Tiruneh MG, Fenta ET, Anagaw TF, et al. Tuberculosis infection control practice and associated factors among health care workers in Ethiopia: Systematic review and meta-analysis. PLoS One, 2023, 18(12): e0295555. doi:10.1371/journal.pone.0295555.
[64]	张婷, 汪清雅, 吴成果, 等. 重庆市市级结核病管理机构医务人员结核感染控制的干预效果分析. 现代预防医学, 2021, 48(6): 1111-1114.